Screener
Immix Biopharma, Inc. IMMX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | 2026 / For the Three Months Ended / March 31, | 2025 / For the Three Months Ended / March 31, |
|---|---|---|
| Total operating expenses | 10,803,855 | 4,682,925 |
| Loss from operations | (10,803,855) | (4,682,925) |
| Other income (expense): | ||
| Interest income | 717,168 | 150,219 |
| Total other income (expense), net | 717,168 | 150,219 |
| Loss before provision for income taxes | (10,086,687) | (4,532,706) |
| Provision for income taxes | - | 9,822 |
| Net loss | (10,086,687) | (4,542,528) |
Document
FAQ
- What is Immix Biopharma, Inc.'s interest income?
- Immix Biopharma, Inc. (IMMX) reported interest income of $717.17K in Q1 2026.
- How has Immix Biopharma, Inc.'s interest income changed year-over-year?
- Immix Biopharma, Inc.'s interest income increased by 377.4% year-over-year, from $150.22K to $717.17K.
- What is the long-term trend for Immix Biopharma, Inc.'s interest income?
- Over 2 years (2023 to 2025), Immix Biopharma, Inc.'s interest income has grown at a -1.5% compound annual growth rate (CAGR), from $572.01K to $555.53K.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Immix Biopharma, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude